Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03656 |
| Species: | Homo sapiens |
| Position : | chr5:893433-1083433 |
| Year: | 2016 |
| Title: | Active medulloblastoma enhancers reveal subgroup-specific cellular origins. |
| Genome Build: | hg19 |
| Enhancer Type: | Super-enhancer |
| Condition: | Disease |
| Disease Name: | Medulloblastoma |
| PMID: | 26814967 |
| MONDO: | MONDO:0007959 |
| Cell Source: | Medulloblastoma Cell Lines |
| Experiment Type: | TF-binding/chromatin assay; Chromatin interaction assay; Disease-associated enhancer analysis |
| High Throughput Method: | ChIP-seq; RNA-seq; 4C-seq |
| Low Throughput Method: | ChIP-qPCR/ChIP; RT-qPCR/qPCR |
| Target gene : | NKD2 |
| TF name : | NANOG |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| NANOG | POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | reactome | 13 |
| NANOG | POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | reactome | 10 |
| NANOG | Transcriptional regulation of pluripotent stem cells | reactome | 28 |